ARCUTIS BIOTHERAPEUTICS, INC.: cashflow_investing
| Value | {"amount": -14221000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-06-30 |
| Status | current |
| Entity | ARCUTIS BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:04:54.683646+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b72be590-8657-4fb2-9e72-94f63e1c92be
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001787306-20-000017Retrieved: 2026-08-19T18:04:54.683646+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001787306/cashflow-investing/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b72be590-8657-4fb2-9e72-94f63e1c92be
History
- no predecessors — first report